Limitations of simulation models for cervical cancer screening - Authors' reply

Affiliations

¹ Division of Cancer Epidemiology, Department of Oncology, McGill University, Montreal, QC H4A 3T2, Canada. Electronic address: talia.malagon@mcgill.ca.
² Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
³ Division of Cancer Epidemiology, Department of Oncology, McGill University, Montreal, QC H4A 3T2, Canada.

Comment

Talía Malagón et al. Lancet Oncol. 2019 Feb.

. 2019 Feb;20(2):e69.

doi: 10.1016/S1470-2045(19)30012-9.

¹ Division of Cancer Epidemiology, Department of Oncology, McGill University, Montreal, QC H4A 3T2, Canada. Electronic address: talia.malagon@mcgill.ca.
² Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
³ Division of Cancer Epidemiology, Department of Oncology, McGill University, Montreal, QC H4A 3T2, Canada.

No abstract available

Comment on

Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.
Malagón T, Kulasingam S, Mayrand MH, Ogilvie G, Smith L, Bouchard C, Gotlieb W, Franco EL. Malagón T, et al. Lancet Oncol. 2018 Dec;19(12):1569-1578. doi: 10.1016/S1470-2045(18)30536-9. Epub 2018 Nov 1. Lancet Oncol. 2018. PMID: 30392810
Limitations of simulation models for cervical cancer screening.
Hammer A, Landy R, Rositch AF, Gravitt PE. Hammer A, et al. Lancet Oncol. 2019 Feb;20(2):e68. doi: 10.1016/S1470-2045(19)30011-7. Lancet Oncol. 2019. PMID: 30712801 Free PMC article. No abstract available.